Susana Chavez-Bueno, MD
Title | Professor of Pediatrics |
---|
Institution | University of Missouri-Kansas City |
---|
Department | Pediatrics |
---|
|
---|
Title | Research Associate Professor of Pediatrics |
---|
Institution | University of Kansas Medical Center |
---|
Department | Pediatrics |
---|
|
---|
|
Biography National Autonomous University of Mexico, Mexico City | MD | 1997 | | Children's Hospital of Oklahoma, Oklahoma City, OK | Residency | 2001 | Pediatrics | University of Texas Southwestern Medical Center, Dallas, TX | Fellowship | 2004 | Pediatric Infectious Disease | University of Texas Southwestern Medical Center at Dallas, Dallas, TX | | 2005 | Postdoctoral Researcher |
2021 | Diversity, Equity & Inclusion Achievement Award, Children’s Mercy Department of Pediatrics | 2013 - 2020 | Best Doctors Database | 2015 - 2016 | Best Doctors in America, Oklahoma Magazine | 2013 | Research Mentor Award, OUHSC Department of Pediatrics Research | 2001 | The Harris D. Riley, Jr. Pediatric Society’s Award, Children’s Hospital of Oklahoma |
Overview Research Dr. Chavez-Bueno’s current research work focuses on the pathogenesis of E. coli sepsis in newborns. Her overall research goal is to identify novel virulence factors relevant to the pathogen’s ability to traverse the gut and invade the bloodstream causing neonatal sepsis. Her studies utilize in vitro and animal models designed to characterize the bacterial components that determine invasion and trafficking across intestinal epithelium and interact with gut specific immune regulators as potential therapeutic targets to decrease life-threatening neonatal E. coli disease.
Dr. Chavez-Bueno is an elected member of the Society for Pediatric Research and member of the Infectious Diseases Society of America.
(Chavez-Bueno)Jan 1, 2002 - Dec 31, 2004 Pediatric Infectious Disease Society (PIDS) Fellowship Award Chemokines in RSV-Induced Airway Hyperresponsiveness |
| (Chavez-Bueno)Jan 1, 2003 - Dec 31, 2003 Clinical Research Support Individual Project Grant, Children’s Medical Center of Dallas Project title: Respiratory Syncytial Virus (RSV) Quantification by Real Time Polymerase Chain Reaction and Markers of Disease Severity in Children |
| MI-CP146 Jan 1, 2007 - Dec 31, 2008 MedImmune A Phase 2, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate a Single Intramuscular Dose of Motavizumab (MEDI-524), a Humanized Enhanced Potency Monoclonal Antibody Against Respiratory Syncytial Virus (RSV), for the Outpatient Treatment of Children with RSV Illness Role: Principal Investigator |
| MI-CP141 Jan 1, 2007 - Dec 31, 2010 MedImmune A Phase 2, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate a Single Intravenous Dose of Motavizumab (MEDI-524), a Humanized Enhanced Potency Monoclonal Antibody Against Respiratory Syncytial Virus (RSV), for the Treatment of Children Hospitalized with RSV Illness Role: Site Principal Investigator |
| Jan 1, 2008 - Dec 31, 2009 ADMA Biologics, Inc A Multicenter, Double-Blind, Randomized, Placebo-Controlled, Dose-Ranging Trial Evaluating the Safety and Efficacy of RI-001 in Medically Immunosupressed Respiratory Syncytial Virus (RSV) Infected Patients at Risk of Lower Respiratory Tract RSV Illness Role: Site Principal Investigator |
| Jan 1, 2008 - Dec 31, 2013 Cubist Pharmaceuticals, Inc An Evaluation of the Safety, Efficacy and Pharmacokinetics of Daptomycin in Pediatric Subjects Aged Seven to Seventeen Years with Complicated Skin and Skin Structure Infections Caused by Gram-Positive Pathogens Role: Site Principal Investigator |
| Jan 1, 2010 - Dec 31, 2011 LaRoche Hoffmann LTD An Open Label, Prospective, Pharmacokinetic/Pharmacodynamic and Safety Evaluation of Intravenous Oseltamivir (Tamiflu®) in the Treatment of Children 1 to 12 years of age with Influenza Infection Role: Site Principal Investigator |
| (Chavez-Bueno)Mar 1, 2012 - Feb 28, 2013 University of Oklahoma Health Sciences Center Vicepresident for research seed grant Escherichia coli K1 Invasive Infections in Neonates Role: Principal Investigator |
| DAP-PEDBAC-11-02 (Aurelia Balan)Nov 19, 2012 - Jan 31, 2014 A Comparative Evaluation of the Safety and Efficacy of Daptomycin versus Standard of Care in Pediatric Subjects Two-Seventeen Years of Age with Bacteremia Caused by Staphylococcus aureus Role: Sub-investigator |
| 8P20GM103447 Jul 1, 2013 - Mar 31, 2014 Oklahoma IDeA Network for Biomedical Research Excellence (INBRE), NIH/NIGMS pilot grant award Escherichia coli K1 Invasive Infections in Neonates Role: Sub-project Principal Investigator |
| (Chavez-Bueno)Jul 1, 2014 - Dec 31, 2015 OUHSC College of Medicine Alumni Association (COMAA) Escherichia Coli Colonization in Women in Preterm Labor Role: Principal Investigator |
| (Akins)Jul 9, 2014 - Aug 5, 2016 Oklahoma IDeA Network for Biomedical Research Excellence (INBRE) Grant, NIH/NIGMS grant award Identification of Virulence Factors in E. coli Strains Causing Neonatal Sepsis Role: Project Principal Investigator |
| (Chavez-Bueno)Sep 1, 2014 - Aug 30, 2016 Oklahoma Center for the Advancement of Science and Technology (OCAST) Bacterial Genes Relevant to Gut Translocation and Virulence in Neonatal Escherichia coli Strains Role: Principal Investigator |
| (Hala Chaaban)Apr 1, 2015 - Aug 1, 2016 NCT01994993: Antibiotic Safety in Infants with Complicated Intra-abdominal Infections, SCAMP Trial Role: Collaborator |
| (Chavez-Bueno)Feb 1, 2016 - Aug 5, 2016 Division of Neonatal-Perinatal medicine, Department of Pediatrics, OUHSC Exposure to low pH Reveals Virulence Factors in Neonatal Escherichia coli Bacteremia after Oral Inoculation Role: Principal Investigator |
| (Chavez-Bueno)Oct 1, 2017 - Sep 30, 2019 Katharine B. Richardson Foundation, Children's Mercy Hospital Role of Bacterial Virulence Factors in the Pathogenesis and Host Response to Neonatal Invasive E. coli Infections Role: Principal Investigator |
| (Chavez-Bueno)Apr 1, 2018 Proteomic profiling of neonates with suspected sepsis Role: Principal Investigator |
| (Chavez-Bueno)Dec 1, 2018 - May 31, 2020 BioNexus KC-Kansas City Area Life Sciences Institute Effects of Probiotics on the Intestinal Microbiome and Inflammatory Response to Infection by Bacteremia-Producing Escherichia coli Role: Principal Investigator |
| (Chavez-Bueno)Oct 1, 2019 - Jun 30, 2022 Marion Merrell Dow Award, , Children's Mercy Hospital Single Immunoglobulin Interleukin-l Related Receptor (SIGIRR) and Escherichia coli Interactions in the Neonatal Gut Role: Principal Investigator |
| (Aashay Patel)Jan 22, 2020 - May 1, 2023 UMKC - School of Medicine Sarah Morrison Student Research Award Escherichia coli Siderophore Receptor IutA as a Virulence Factor in Neonatal Sepsis Role: Mentor |
| (Adnan Islam)Jan 22, 2020 - May 1, 2023 Sarah Morrison Student Research Award Role of rfaZ in Pathogenesis of Escherichia coli Neonatal Sepsis Role: Mentor |
| (Alain Cuna)Aug 1, 2020 - Jul 31, 2025 NIH K08 Award (NIDDKD) Gene-environment interactions in necrotizing enterocolitis: the impact of SIGIRR mutation and gut microbiota on intestinal TLR hyperactivity Role: Co-Investigator |
| (Venkatesh Sampath)Dec 1, 2020 Genetic Susceptibility to Neonatal Diseases Repository Role: Co-Investigator |
| (Chavez-Bueno)Jun 1, 2021 - Jun 30, 2022 CMRI Innovator Incubator Award “Prenatal Lactoferrin for Newborn Health” Role Description: To study the administration of lactoferrin to pregnant animals to prevent neonatal E. coli infection. Role: Principal Investigator |
| (Chavez-Bueno)Jul 1, 2022 - Dec 31, 2023 Children’s Mercy Research Partners Award “Lactoferrin in Pregnancy for Newborn Health” Role Description: To develop a lactoferrin formulation to be used during pregnancy to prevent neonatal E. coli infection Role: Principal Investigator |
| (Chavez-Bueno)Oct 1, 2023 - Sep 30, 2025 Katharine B. Richardson (KBR) Award Prenatal Lactoferrin to Mitigate Escherichia coli-induced Preterm Delivery and Neonatal Sepsis Role Description: To determine the role of maternal lactoferrin administration on ameliorating E. coli-induced preterm delivery and neonatal invasive infection Role: Principal Investigator |
| (Keerti Ivaturi-UMKC-SOM medical student))Nov 1, 2023 - May 1, 2027 UMKC School of Medicine Clinical Characteristics, Antibiotic Resistance and Molecular Epidemiology of Escherichia coli Isolates Producing Neonatal Septicemia Role: Mentor |
Bibliography
-
Godwin J, Daniel J, Chavez-Bueno S, Sampath V. Insight Into Severe Neonatal COVID-19 Gained Through Whole Exome Sequencing of Twin Neonates. Pediatr Infect Dis J. 2024 Jul 31. PMID: 39082788.
-
Arredondo-Alonso S, Blundell-Hunter G, Fu Z, Gladstone RA, Fillol-Salom A, Loraine J, Cloutman-Green E, Johnsen PJ, Samuelsen ?, P?ntinen AK, Cl?on F, Chavez-Bueno S, De la Cruz MA, Ares MA, Vongsouvath M, Chmielarczyk A, Horner C, Klein N, McNally A, Reis JN, Penad?s JR, Thomson NR, Corander J, Taylor PW, McCarthy AJ. Evolutionary and functional history of the Escherichia coli K1 capsule. Nat Commun. 2023 06 15; 14(1):3294. PMID: 37322051.
-
Cuna A, Nsumu M, Menden HL, Chavez-Bueno S, Sampath V. The Detrimental Effects of Peripartum Antibiotics on Gut Proliferation and Formula Feeding Injury in Neonatal Mice Are Alleviated with Lactobacillus rhamnosus GG. Microorganisms. 2023 Jun 01; 11(6). PMID: 37374984.
-
Islam A, Wheatley JL, Chavez-Bueno S. Assessment of Intestinal Transcytosis of Neonatal Escherichia coli Bacteremia Isolates. J Vis Exp. 2023 02 17; (192). PMID: 36876937.
-
Rao K, Cuna A, Chavez-Bueno S, Menden H, Yu W, Ahmed I, Srinivasan P, Umar S, Sampath V. Effect of Various Preterm Infant Milk Formulas on NEC-Like Gut Injury in Mice. Front Pediatr. 2022; 10:902798. PMID: 35874567.
-
Williams M, Jones AB, Maxedon AL, Tabakh JE, McCloskey CB, Bard DE, Heruth DP, Chavez-Bueno S. Whole-genome sequencing-based phylogeny, antibiotic resistance, and invasive phenotype of Escherichia coli strains colonizing the cervix of women in preterm labor. BMC Microbiol. 2021 12 03; 21(1):330. PMID: 34861816.
-
Cuna A, Yu W, Menden HL, Feng L, Srinivasan P, Chavez-Bueno S, Ahmed I, Umar S, Sampath V. NEC-like intestinal injury is ameliorated by Lactobacillus rhamnosus GG in parallel with SIGIRR and A20 induction in neonatal mice. Pediatr Res. 2020 10; 88(4):546-555. PMID: 32053825.
-
Cole BK, Ilikj M, McCloskey CB, Chavez-Bueno S. Antibiotic resistance and molecular characterization of bacteremia Escherichia coli isolates from newborns in the United States. PLoS One. 2019; 14(7):e0219352. PMID: 31276562.
-
Rodriguez-Fernandez R, Tapia LI, Yang CF, Torres JP, Chavez-Bueno S, Garcia C, Jaramillo LM, Moore-Clingenpeel M, Jafri HS, Peeples ME, Piedra PA, Ramilo O, Mejias A. Respiratory Syncytial Virus Genotypes, Host Immune Profiles, and Disease Severity in Young Children Hospitalized With Bronchiolitis. J Infect Dis. 2017 12 27; 217(1):24-34. PMID: 29045741.
-
Cole BK, Scott E, Ilikj M, Bard D, Akins DR, Dyer DW, Chavez-Bueno S. Route of infection alters virulence of neonatal septicemia Escherichia coli clinical isolates. PLoS One. 2017; 12(12):e0189032. PMID: 29236742.
-
Ugas MB, Carroll T, Kovar L, Chavez-Bueno S. Salmonella Typhi-Induced Septic Shock and Acute Respiratory Distress Syndrome in a Previously Healthy Teenage Patient Treated With High-Dose Dexamethasone. J Investig Med High Impact Case Rep. 2016 Apr-Jun; 4(2):2324709616652642. PMID: 27294165.
-
Williams M, Maxedon A, McCloskey C, Bard D, Chavez-Bueno S;. Prevalence of Escherichia coli Cervical Colonization in Women in Preterm Labor. Obstetrics & Gynecology. 2016; 127:70S.
-
Benefield EC, Hagemann TM, Allen HC, Farmer K, Burton ME, Chavez-Bueno S, Johnson PN. Vancomycin Dosing and Pharmacokinetics in Postoperative Pediatric Cardiothoracic Surgery Patients. J Pediatr Pharmacol Ther. 2016 Jan-Feb; 21(1):66-74. PMID: 26997930.
-
Day MW, Jackson LA, Akins DR, Dyer DW, Chavez-Bueno S. Whole-Genome Sequences of the Archetypal K1 Escherichia coli Neonatal Isolate RS218 and Contemporary Neonatal Bacteremia Clinical Isolates SCB11, SCB12, and SCB15. Genome Announc. 2015 Feb 26; 3(1). PMID: 25720688.
-
Chavez-Bueno S, Day MW, Toby IT, Akins DR, Dyer DW. Genome Sequence of SCB34, a Sequence Type 131 Multidrug-Resistant Escherichia coli Isolate Causing Neonatal Early-Onset Sepsis. Genome Announc. 2014 Jun 12; 2(3). PMID: 24926049.
-
Shakir SM, Goldbeck JM, Robison D, Eckerd AM, Chavez-Bueno S. Genotypic and phenotypic characterization of invasive neonatal Escherichia coli clinical isolates. Am J Perinatol. 2014 Nov; 31(11):975-82. PMID: 24566757.
-
Miller M, Miller JL, Hagemann TM, Harrison D, Chavez-Bueno S, Johnson PN. Vancomycin dosage in overweight and obese children. Am J Health Syst Pharm. 2011 Nov 01; 68(21):2062-8. PMID: 22011985.
-
Chavez-Bueno S, Beasley JA, Goldbeck JM, Bright BC, Morton DJ, Whitby PW, Stull TL. 'Haptoglobin concentrations in preterm and term newborns'. J Perinatol. 2011 Jul; 31(7):500-3. PMID: 21252963.
-
Ch?vez-Bueno S, Stull TL. Pediatric vaccines on the horizon. Am J Med Sci. 2010 Sep; 340(3):226-31. PMID: 20697256.
-
Chavez-Bueno S, Stull TL. Antibacterial agents in pediatrics. Infect Dis Clin North Am. 2009 Dec; 23(4):865-80, viii. PMID: 19909888.
-
Mej?as A, Ch?vez-Bueno S, G?mez AM, Somers C, Estripeaut D, Torres JP, Jafri HS, Ramilo O. Respiratory syncytial virus persistence: evidence in the mouse model. Pediatr Infect Dis J. 2008 Oct; 27(10 Suppl):S60-2. PMID: 18820580.
-
Ch?vez-Bueno S, Mej?as A, Merryman RA, Ahmad N, Jafri HS, Ramilo O. Intravenous palivizumab and ribavirin combination for respiratory syncytial virus disease in high-risk pediatric patients. Pediatr Infect Dis J. 2007 Dec; 26(12):1089-93. PMID: 18043443.
-
Mej?as A, Ch?vez-Bueno S, Raynor MB, Connolly J, Kiener PA, Jafri HS, Ramilo O. Motavizumab, a neutralizing anti-Respiratory Syncytial Virus (Rsv) monoclonal antibody significantly modifies the local and systemic cytokine responses induced by Rsv in the mouse model. Virol J. 2007 Oct 25; 4:109. PMID: 17961258.
-
Bogdanovich T, Aydin N, Chavez-Bueno S, McCracken G, Bozdogan B, Appelbaum PC. Genetic characterization of erythromycin- and methicillin-resistant community-acquired Staphylococcus aureus isolated from children in Texas. Diagn Microbiol Infect Dis. 2007 Oct; 59(2):231-3. PMID: 17662559.
-
Welliver TP, Garofalo RP, Hosakote Y, Hintz KH, Avendano L, Sanchez K, Velozo L, Jafri H, Chavez-Bueno S, Ogra PL, McKinney L, Reed JL, Welliver RC. Severe human lower respiratory tract illness caused by respiratory syncytial virus and influenza virus is characterized by the absence of pulmonary cytotoxic lymphocyte responses. J Infect Dis. 2007 Apr 15; 195(8):1126-36. PMID: 17357048.
-
Yusuf S, Piedimonte G, Auais A, Demmler G, Krishnan S, Van Caeseele P, Singleton R, Broor S, Parveen S, Avendano L, Parra J, Chavez-Bueno S, Murgu?a De Sierra T, Simoes EA, Shaha S, Welliver R. The relationship of meteorological conditions to the epidemic activity of respiratory syncytial virus. Epidemiol Infect. 2007 Oct; 135(7):1077-90. PMID: 17346359.
-
Salvatore CM, Fonseca-Aten M, Katz-Gaynor K, Gomez AM, Mejias A, Somers C, Chavez-Bueno S, McCracken GH, Hardy RD. Respiratory tract infection with Mycoplasma pneumoniae in interleukin-12 knockout mice results in improved bacterial clearance and reduced pulmonary inflammation. Infect Immun. 2007 Jan; 75(1):236-42. PMID: 17074851.
-
Fonseca-Aten M, Okada PJ, Bowlware KL, Chavez-Bueno S, Mejias A, Rios AM, Katz K, Olsen K, Ng S, Jafri HS, McCracken GH, Ramilo O, Hardy RD. Effect of clarithromycin on cytokines and chemokines in children with an acute exacerbation of recurrent wheezing: a double-blind, randomized, placebo-controlled trial. Ann Allergy Asthma Immunol. 2006 Oct; 97(4):457-63. PMID: 17069099.
-
Fonseca-Aten M, Rios AM, Mejias A, Chavez-Bueno S, Katz K, Gomez AM, Ramilo O, McCracken GH, Hardy RD. Treatment of experimental chronic pulmonary mycoplasmosis. Int J Antimicrob Agents. 2006 Sep; 28(3):253-8. PMID: 16891098.
-
Ch?vez-Bueno S, Mej?as A, Welliver RC. Respiratory syncytial virus bronchiolitis : current and future strategies for treatment and prophylaxis. Treat Respir Med. 2006; 5(6):483-94. PMID: 17154675.
-
Mej?as A, Ch?vez-Bueno S, Jafri HS, Ramilo O. Respiratory syncytial virus infections: old challenges and new opportunities. Pediatr Infect Dis J. 2005 Nov; 24(11 Suppl):S189-96, discussion S196-7. PMID: 16378045.
-
Mej?as A, Ch?vez-Bueno S, R?os AM, Aten MF, Raynor B, Peromingo E, Soni P, Olsen KD, Kiener PA, G?mez AM, Jafri HS, Ramilo O. Comparative effects of two neutralizing anti-respiratory syncytial virus (RSV) monoclonal antibodies in the RSV murine model: time versus potency. Antimicrob Agents Chemother. 2005 Nov; 49(11):4700-7. PMID: 16251314.
-
Fonseca-Aten M, Salvatore CM, Mej?as A, R?os AM, Ch?vez-Bueno S, Katz K, G?mez AM, McCracken GH, Hardy RD. Evaluation of LBM415 (NVP PDF-713), a novel peptide deformylase inhibitor, for treatment of experimental Mycoplasma pneumoniae pneumonia. Antimicrob Agents Chemother. 2005 Oct; 49(10):4128-36. PMID: 16189089.
-
R?os AM, Fonseca-Aten M, Mej?as A, Ch?vez-Bueno S, Katz K, G?mez AM, McCracken GH, Ramilo O, Hardy RD. Microbiologic and immunologic evaluation of a single high dose of azithromycin for treatment of experimental Mycoplasma pneumoniae pneumonia. Antimicrob Agents Chemother. 2005 Sep; 49(9):3970-3. PMID: 16127085.
-
Mej?as A, Ch?vez-Bueno S, Ramilo O. Respiratory syncytial virus pneumonia: mechanisms of inflammation and prolonged airway hyperresponsiveness. Curr Opin Infect Dis. 2005 Jun; 18(3):199-204. PMID: 15864095.
-
Ch?vez-Bueno S, McCracken GH. Bacterial meningitis in children. Pediatr Clin North Am. 2005 Jun; 52(3):795-810, vii. PMID: 15925663.
-
Chavez-Bueno S, Bozdogan B, Katz K, Bowlware KL, Cushion N, Cavuoti D, Ahmad N, McCracken GH, Appelbaum PC. Inducible clindamycin resistance and molecular epidemiologic trends of pediatric community-acquired methicillin-resistant Staphylococcus aureus in Dallas, Texas. Antimicrob Agents Chemother. 2005 Jun; 49(6):2283-8. PMID: 15917522.
-
Ch?vez-Bueno S, Mej?as A, G?mez AM, Olsen KD, R?os AM, Fonseca-Aten M, Ramilo O, Jafri HS. Respiratory syncytial virus-induced acute and chronic airway disease is independent of genetic background: an experimental murine model. Virol J. 2005 May 25; 2:46. PMID: 15916706.
-
Ch?vez-Bueno S, Mej?as A, Jafri HS, Ramilo O. Respiratory syncytial virus: old challenges and new approaches. Pediatr Ann. 2005 Jan; 34(1):62-8. PMID: 15693217.
-
Fonseca-Aten M, R?os AM, Mej?as A, Ch?vez-Bueno S, Katz K, G?mez AM, McCracken GH, Hardy RD. Mycoplasma pneumoniae induces host-dependent pulmonary inflammation and airway obstruction in mice. Am J Respir Cell Mol Biol. 2005 Mar; 32(3):201-10. PMID: 15626776.
-
Mej?as A, Ch?vez-Bueno S, R?os AM, Fonseca-Aten M, G?mez AM, Jafri HS, Ramilo O. [Asthma and respiratory syncytial virus. New opportunities for therapeutic intervention]. An Pediatr (Barc). 2004 Sep; 61(3):252-60. PMID: 15469810.
-
R?os AM, Mej?as A, Ch?vez-Bueno S, Fonseca-Aten M, Katz K, Hatfield J, G?mez AM, Jafri HS, McCracken GH, Ramilo O, Hardy RD. Impact of cethromycin (ABT-773) therapy on microbiological, histologic, immunologic, and respiratory indices in a murine model of Mycoplasma pneumoniae lower respiratory infection. Antimicrob Agents Chemother. 2004 Aug; 48(8):2897-904. PMID: 15273098.
-
Mej?as A, Ch?vez-Bueno S, R?os AM, Saavedra-Lozano J, Fonseca Aten M, Hatfield J, Kapur P, G?mez AM, Jafri HS, Ramilo O. Anti-respiratory syncytial virus (RSV) neutralizing antibody decreases lung inflammation, airway obstruction, and airway hyperresponsiveness in a murine RSV model. Antimicrob Agents Chemother. 2004 May; 48(5):1811-22. PMID: 15105140.
-
Jafri HS, Chavez-Bueno S, Mejias A, Gomez AM, Rios AM, Nassi SS, Yusuf M, Kapur P, Hardy RD, Hatfield J, Rogers BB, Krisher K, Ramilo O. Respiratory syncytial virus induces pneumonia, cytokine response, airway obstruction, and chronic inflammatory infiltrates associated with long-term airway hyperresponsiveness in mice. J Infect Dis. 2004 May 15; 189(10):1856-65. PMID: 15122522.
-
Mej?as A, Ch?vez-Bueno S, Ramilo O. Human metapneumovirus: a not so new virus. Pediatr Infect Dis J. 2004 Jan; 23(1):1-7; quiz 8-10. PMID: 14743038.
-
Hardy RD, Rios AM, Chavez-Bueno S, Jafri HS, Hatfield J, Rogers BB, McCracken GH, Ramilo O. Antimicrobial and immunologic activities of clarithromycin in a murine model of Mycoplasma pneumoniae-induced pneumonia. Antimicrob Agents Chemother. 2003 May; 47(5):1614-20. PMID: 12709330.
-
Mendoza-Alvarez H, Chavez-Bueno S, Alvarez-Gonzalez R. Chain length analysis of ADP-ribose polymers generated by poly(ADP-ribose) polymerase (PARP) as a function of beta-NAD+ and enzyme concentrations. IUBMB Life. 2000 Aug; 50(2):145-9. PMID: 11185961.
This graph shows the total number of publications by year, by first, middle/unknown, or last author.
To see the data from this visualization as text, click here.
Year | Publications |
---|
2000 | 1 | 2003 | 1 | 2004 | 6 | 2005 | 9 | 2006 | 4 | 2007 | 5 | 2008 | 1 | 2009 | 1 | 2010 | 1 | 2011 | 2 | 2014 | 2 | 2015 | 1 | 2016 | 3 | 2017 | 2 | 2019 | 1 | 2020 | 1 | 2021 | 1 | 2022 | 1 | 2023 | 3 | 2024 | 1 |
To return to the timeline, click here.
|
Click the "See All" links for more information and interactive visualizations!
Concepts Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
|